Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea

  • Shim, Ji-Su
  • Jin, Juhae
  • Kim, Sae-Hoon
  • Lee, Taehoon
  • Jang, An-Soo
  • ... Hur, Gyu Young
  • 외 25명
Citations

WEB OF SCIENCE

3
Citations

SCOPUS

3

초록

338489296_20221221170722203 responders; 2) doctor-diagnosed asthma-chronic obstructive pulmonary disease overlap (ACO) [OR = 12.6, 95% CI: 1.8-161.5, P = 0.024], and 3) initial ACT score <20 [OR = 24.1, 95% CI: 5.45- 158.8, P < 0.001] for ACT responders. FEV1 responders also showed a longer exacerbation-free period than those with no FEV1 increase (P = 0.014), yielding a hazard ratio for the first asthma exacerbation of 0.5 (95% CI: 0.3-0.9, P = 0.016). Conclusions: The results of this study suggest that tiotropium add-on for uncontrolled asthma with ICS-LABA would be more effective in patients with positive BDR or ACO. Additionally, an increase in FEV1 following tiotropium may predict a lower risk of asthma exacerbation.

키워드

TiotropiumMuscarinic antagonistsAsthmaTreatment responsePredictorEXACERBATIONMANAGEMENTBROMIDE
제목
Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea
저자
Shim, Ji-SuJin, JuhaeKim, Sae-HoonLee, TaehoonJang, An-SooPark, Chan SunJung, Jae-WooKwon, Jae-WooMoon, Ji-YongYang, Min-SukLee, JaechunChoi, Jeong-HeeShin, Yoo SeobKim, Hee-KyooKim, SujeongKim, Joo-HeeCho, Sang-HeonNam, Young-HeeKim, Sang-HoonPark, So YoungHur, Gyu YoungKim, Sang-HaPark, Hye-KyungJin, Hyun JungLee, Jae-HyunPark, Jung-WonYoon, Ho JooChoi, Byoung WhuiCho, Young-JooKim, Min-HyeKim, Tae-Bum
DOI
10.1016/j.waojou.2022.100720
발행일
2022-12
유형
Article
저널명
World Allergy Organization Journal
15
12